Antirheumatic Drugs, Disease-Modifying [phsu]
Methotrexate [orch, phsu]
Rheumatoid Arthritis [dsyn]
Seronegative arthritis [dsyn]
Purpose [ftcn]
findings [ftcn]
Antirheumatic Drugs, Disease-Modifying [phsu]
Rheumatoid Arthritis [dsyn]
Seronegative arthritis [dsyn]
Span [cnce]
Review, Systematic [inpr]
randomized controlled trials [inpr, resa]
observation - clinical trial [idcn]
practice [menp]
assessments [hlca]
adverse effects [ftcn]
findings [ftcn]
Review, Systematic [inpr]
Methotrexate [orch, phsu]
leflunomide [orch, phsu]
Sulfasalazine [orch, phsu]
Early Therapy [topp]
Antirheumatic Drugs, Disease-Modifying [phsu]
Erosive [qlco]
progression [patf]
Observational Study [resa]
Antirheumatic Drugs, Disease-Modifying [phsu]
prescribed [hlca]
Usage [ftcn]
Increased [qnco]
Biologic [qlco]
Systemic [ftcn]
Patients [podg]
Failed [ftcn]
Benefit [qnco]
Antirheumatic Drugs, Disease-Modifying [phsu]
Combinations [mnob]
Excess [qlco]
toxicity [qlco]
randomized controlled trials [inpr, resa]
Initial [tmco]
Antirheumatic Drugs, Disease-Modifying [phsu]
Combinations [mnob]
Synovitis [dsyn]
Erosive [qlco]
Damage [inpo]
Steroids [strd]
Subsequent [tmco]
Sequence [nusq]
Antirheumatic Drugs, Disease-Modifying [phsu]
Value [qnco]
Changing [ftcn]
Antirheumatic Drugs, Disease-Modifying [phsu]
stepping [sosy]
Combination [qlco]
Antirheumatic Drugs, Disease-Modifying [phsu]
Unresolved [qlco]
Risks [qlco]
Antirheumatic Drugs, Disease-Modifying [phsu]
Evaluated [ftcn]
Including [ftcn]
Infections [dsyn]
Lung disease NOS [dsyn]
Risks [qlco]
Drug [phsu]
Risks [qlco]
Several [qnco]
Antirheumatic Drugs, Disease-Modifying [phsu]
Types [qlco]
Adverse reactions [fndg]
limitations [ftcn]
Antirheumatic Drugs, Disease-Modifying [phsu]
Reduced [qlco]
IMPACT [gngm]
Cardiovascular disease [dsyn]
Reduced [qlco]
Clinician [prog]
Preferences [idcn]
Treatments [topp]
summary [inpr]
Antirheumatic Drugs, Disease-Modifying [phsu]
effective [qlco]
Well [qlco]
treatment [ftcn]
strategies [menp]
Rheumatoid Arthritis [dsyn]
APPEAR [qlco]
